Search Results - "HÖRZER, Helen"
-
1
Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10–12, 2016
Published in Cancer Immunology, Immunotherapy (01-05-2017)Get full text
Journal Article Conference Proceeding -
2
Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer
Published in Cancer Immunology, Immunotherapy (01-09-2013)“…Introduction Lung cancer is the most common cancer worldwide. Every year, as many people die of lung cancer as of breast, colon and rectum cancers combined…”
Get full text
Journal Article -
3
Abstract 662: IMA_Detect: Mass spectrometry guided development and clinical application of a companion diagnostic for adoptive cellular therapy against tumor associated HLA peptides
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Adoptive cellular therapy (ACT) has dramatically changed the landscape of cancer immunotherapy. ACTolog® and ACTengine® are actively personalized ACT…”
Get full text
Journal Article -
4
Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection
Published in Proteomics (Weinheim) (01-06-2018)“…Immunotherapy is revolutionizing cancer treatment and has shown success in particular for tumors with a high mutational load. These effects have been linked to…”
Get full text
Journal Article -
5
Front Cover: Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection
Published in Proteomics (Weinheim) (01-06-2018)“…DOI: 10.1002/pmic.201700284 Translation from immunopeptidomics to HLA peptide target to TCR lead to cancer immunotherapy. Cancer antigen Ag007‐01 (blue) bound…”
Get full text
Journal Article -
6
HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy
Published in Oncoimmunology (03-05-2016)“…The recent approval of clincially effective immune checkpoint inhibitors illustrates the potential of cancer immunotherapy. A challenging task remains the…”
Get full text
Journal Article -
7
Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and β1 integrin
Published in International journal of oncology (01-12-2011)Get full text
Journal Article -
8
Automated overexpression and isotopic labelling of biologically active oncoproteins in the cyanobacterium Anabaena sp. PCC 7120
Published in Biotechnology and applied biochemistry (01-09-2008)“…We have previously shown the cyanobacterium Anabaena sp. PCC 7120 to be a suitable host for the production of isotopically labelled recombinant proteins using…”
Get full text
Journal Article -
9
Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and β1 integrin
Published in International journal of oncology (01-12-2011)“…Peritoneal carcinomatosis describes cancer metastasis onto the surface of the peritoneum. It is frequently caused by ovarian and colorectal cancer. Once a…”
Get more information
Journal Article